Agenus | AGEN - Ebit



金融业
股票价格
USD
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 3.37B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


Ebit 更改 日
AbbVie USD 6.72B 1.99B 2026-06
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Incyte USD 700.4M 356.23M 2026-06
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 7.48B 860M 2026-06
Jiangsu Hengrui CNY 1.68B 876.54M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -31.88M 19.79M 2026-03
Merck EUR 1.1B 51M 2026-06
Merck USD 840M 2.72B 2026-06
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Novartis USD 4.73B 549M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD -180M 5.16B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 23.96M 4.88M 2026-06